CMS Indecisive On New Add-On Payment Candidates
This article was originally published in The Gray Sheet
Executive Summary
Medtronic's Restore rechargeable implantable neurostimulator would continue to get federal add-on payments but its older Kinetra neurostimulator would not if CMS solidifies its proposed inpatient prospective payment rules for fiscal year 2007